Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3

Arul M. Chinnaiyan, William L. Hanna, Kim Orth, Hangjun Duan, Guy G. Poirier, Christopher J. Froelich, Vishva M. Dixit

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells provide immune surveillance against viruses and neoplasms, and play a central role in the pathogenesis of autoimmune disease, AIDS and graft rejection [1,2]. Thus, it is important to understand the precise molecular mechanism(s) whereby cytotoxic lymphocytes destroy susceptible target cells. Granule- mediated cytotoxicity requires a combination of both perforin and granzyme B [3]. Perforin polymerizes to form transmembrane channels and presumably allows granzyme B access to target cell substrates, which until recently, were unknown. One clue to the identity of the physiological substrate(s) activated by granzyme B comes from its unusual specificity for denying synthetic substrates after aspartate residues [4]. Members of the ICE/CED-3 family of cysteine proteases are prime candidates as they are important apoptotic effectors [5,6] and are expressed as zymogens, which can be processed to form active heterodimeric enzymes after cleavage at specific aspartate residues. Previous studies have shown that granzyme B proteolytically activates the cell death effector Yama/CPP32/apopain [7,8] (referred to hera is Yama). Here we report that granzyme B also activates ICE-LAP3/Mch3/CMH-1 (referred to here as ICE-LAP3), which, along with Yama and MCh2, forms a subset of the ICE/CED-3 family of cysteine proteases most closely related to the Caenorhabditis elegans cell death gene, CED-3 [6,9]. Importantly, Jurkat T cells incubated with granzyme B end u sublyric concentration of perforin undergo apoptosis, which is preceded by the activation of endogenous ICE-LAP3. Thus, we propose that granzyme B mediates apoptosis by directly engaging the target cell's death effector machinery, which is probably composed of an arsenal of intracellular, CED-3-like cysteine proteases.

Original languageEnglish (US)
Pages (from-to)897-899
Number of pages3
JournalCurrent Biology
Volume6
Issue number7
DOIs
StatePublished - Jul 1 1996

Fingerprint

Granzymes
Caspase 1
T-cells
cysteine proteinases
cell death
proteinases
T-lymphocytes
aspartic acid
T-Lymphocytes
Cysteine Proteases
Cell death
apoptosis
zymogens
graft rejection
Perforin
cytotoxic T-lymphocytes
autoimmune diseases
natural killer cells
Caenorhabditis elegans
Cell Death

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)

Cite this

Chinnaiyan, A. M., Hanna, W. L., Orth, K., Duan, H., Poirier, G. G., Froelich, C. J., & Dixit, V. M. (1996). Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3. Current Biology, 6(7), 897-899. https://doi.org/10.1016/S0960-9822(02)00614-0

Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3. / Chinnaiyan, Arul M.; Hanna, William L.; Orth, Kim; Duan, Hangjun; Poirier, Guy G.; Froelich, Christopher J.; Dixit, Vishva M.

In: Current Biology, Vol. 6, No. 7, 01.07.1996, p. 897-899.

Research output: Contribution to journalArticle

Chinnaiyan, AM, Hanna, WL, Orth, K, Duan, H, Poirier, GG, Froelich, CJ & Dixit, VM 1996, 'Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3', Current Biology, vol. 6, no. 7, pp. 897-899. https://doi.org/10.1016/S0960-9822(02)00614-0
Chinnaiyan, Arul M. ; Hanna, William L. ; Orth, Kim ; Duan, Hangjun ; Poirier, Guy G. ; Froelich, Christopher J. ; Dixit, Vishva M. / Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3. In: Current Biology. 1996 ; Vol. 6, No. 7. pp. 897-899.
@article{ed516873e1264c79a4c02771cdcd86d2,
title = "Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3",
abstract = "Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells provide immune surveillance against viruses and neoplasms, and play a central role in the pathogenesis of autoimmune disease, AIDS and graft rejection [1,2]. Thus, it is important to understand the precise molecular mechanism(s) whereby cytotoxic lymphocytes destroy susceptible target cells. Granule- mediated cytotoxicity requires a combination of both perforin and granzyme B [3]. Perforin polymerizes to form transmembrane channels and presumably allows granzyme B access to target cell substrates, which until recently, were unknown. One clue to the identity of the physiological substrate(s) activated by granzyme B comes from its unusual specificity for denying synthetic substrates after aspartate residues [4]. Members of the ICE/CED-3 family of cysteine proteases are prime candidates as they are important apoptotic effectors [5,6] and are expressed as zymogens, which can be processed to form active heterodimeric enzymes after cleavage at specific aspartate residues. Previous studies have shown that granzyme B proteolytically activates the cell death effector Yama/CPP32/apopain [7,8] (referred to hera is Yama). Here we report that granzyme B also activates ICE-LAP3/Mch3/CMH-1 (referred to here as ICE-LAP3), which, along with Yama and MCh2, forms a subset of the ICE/CED-3 family of cysteine proteases most closely related to the Caenorhabditis elegans cell death gene, CED-3 [6,9]. Importantly, Jurkat T cells incubated with granzyme B end u sublyric concentration of perforin undergo apoptosis, which is preceded by the activation of endogenous ICE-LAP3. Thus, we propose that granzyme B mediates apoptosis by directly engaging the target cell's death effector machinery, which is probably composed of an arsenal of intracellular, CED-3-like cysteine proteases.",
author = "Chinnaiyan, {Arul M.} and Hanna, {William L.} and Kim Orth and Hangjun Duan and Poirier, {Guy G.} and Froelich, {Christopher J.} and Dixit, {Vishva M.}",
year = "1996",
month = "7",
day = "1",
doi = "10.1016/S0960-9822(02)00614-0",
language = "English (US)",
volume = "6",
pages = "897--899",
journal = "Current Biology",
issn = "0960-9822",
publisher = "Cell Press",
number = "7",

}

TY - JOUR

T1 - Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3

AU - Chinnaiyan, Arul M.

AU - Hanna, William L.

AU - Orth, Kim

AU - Duan, Hangjun

AU - Poirier, Guy G.

AU - Froelich, Christopher J.

AU - Dixit, Vishva M.

PY - 1996/7/1

Y1 - 1996/7/1

N2 - Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells provide immune surveillance against viruses and neoplasms, and play a central role in the pathogenesis of autoimmune disease, AIDS and graft rejection [1,2]. Thus, it is important to understand the precise molecular mechanism(s) whereby cytotoxic lymphocytes destroy susceptible target cells. Granule- mediated cytotoxicity requires a combination of both perforin and granzyme B [3]. Perforin polymerizes to form transmembrane channels and presumably allows granzyme B access to target cell substrates, which until recently, were unknown. One clue to the identity of the physiological substrate(s) activated by granzyme B comes from its unusual specificity for denying synthetic substrates after aspartate residues [4]. Members of the ICE/CED-3 family of cysteine proteases are prime candidates as they are important apoptotic effectors [5,6] and are expressed as zymogens, which can be processed to form active heterodimeric enzymes after cleavage at specific aspartate residues. Previous studies have shown that granzyme B proteolytically activates the cell death effector Yama/CPP32/apopain [7,8] (referred to hera is Yama). Here we report that granzyme B also activates ICE-LAP3/Mch3/CMH-1 (referred to here as ICE-LAP3), which, along with Yama and MCh2, forms a subset of the ICE/CED-3 family of cysteine proteases most closely related to the Caenorhabditis elegans cell death gene, CED-3 [6,9]. Importantly, Jurkat T cells incubated with granzyme B end u sublyric concentration of perforin undergo apoptosis, which is preceded by the activation of endogenous ICE-LAP3. Thus, we propose that granzyme B mediates apoptosis by directly engaging the target cell's death effector machinery, which is probably composed of an arsenal of intracellular, CED-3-like cysteine proteases.

AB - Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells provide immune surveillance against viruses and neoplasms, and play a central role in the pathogenesis of autoimmune disease, AIDS and graft rejection [1,2]. Thus, it is important to understand the precise molecular mechanism(s) whereby cytotoxic lymphocytes destroy susceptible target cells. Granule- mediated cytotoxicity requires a combination of both perforin and granzyme B [3]. Perforin polymerizes to form transmembrane channels and presumably allows granzyme B access to target cell substrates, which until recently, were unknown. One clue to the identity of the physiological substrate(s) activated by granzyme B comes from its unusual specificity for denying synthetic substrates after aspartate residues [4]. Members of the ICE/CED-3 family of cysteine proteases are prime candidates as they are important apoptotic effectors [5,6] and are expressed as zymogens, which can be processed to form active heterodimeric enzymes after cleavage at specific aspartate residues. Previous studies have shown that granzyme B proteolytically activates the cell death effector Yama/CPP32/apopain [7,8] (referred to hera is Yama). Here we report that granzyme B also activates ICE-LAP3/Mch3/CMH-1 (referred to here as ICE-LAP3), which, along with Yama and MCh2, forms a subset of the ICE/CED-3 family of cysteine proteases most closely related to the Caenorhabditis elegans cell death gene, CED-3 [6,9]. Importantly, Jurkat T cells incubated with granzyme B end u sublyric concentration of perforin undergo apoptosis, which is preceded by the activation of endogenous ICE-LAP3. Thus, we propose that granzyme B mediates apoptosis by directly engaging the target cell's death effector machinery, which is probably composed of an arsenal of intracellular, CED-3-like cysteine proteases.

UR - http://www.scopus.com/inward/record.url?scp=0030198505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030198505&partnerID=8YFLogxK

U2 - 10.1016/S0960-9822(02)00614-0

DO - 10.1016/S0960-9822(02)00614-0

M3 - Article

C2 - 8805307

AN - SCOPUS:0030198505

VL - 6

SP - 897

EP - 899

JO - Current Biology

JF - Current Biology

SN - 0960-9822

IS - 7

ER -